Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-25-017223

Chief Executive Officer acquired 66,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-09 Exercise or conversion : show line 1 in the form +66,667 $3.30 $220,001 1,038,981 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-09 Exercise or conversion : show line 2 in the form Stock Options (right to buy) −66,667 0 D
Loading xslF345X05/wk-form4_1744242755.xml…